TrialArthritis research & therapy2022

Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trial.

Thomas Dörner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.